BSE: 532067 | NSE: | Pesticides & Agrochemicals | Small Cap
Past 10 year's financial track record analysis by Moneyworks4me indicates that 3B Blackbio Dx Ltd is a average quality company.
The key valuation ratios of 3B Blackbio Dx Ltd's currently when compared to its past seem to suggest it is in the Somewhat overvalued zone.
The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of 3B Blackbio Dx Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
Value Creation Index Colour Code Guide ⓘ
| Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % ⓘ | 6.1% | 4.8% | 5.5% | 6.1% | 4.2% | 4.1% | 9.5% | 33.5% | 10.8% | 36.6% | - |
| Value Creation Index ⓘ | -0.6 | -0.7 | -0.6 | -0.6 | -0.7 | -0.7 | -0.3 | 1.4 | -0.2 | 1.6 | - |
Growth Parameters ⓘGrowth Parameters Colour Code Guide ⓘ | |||||||||||
| Sales ⓘ | 17.9 | 15.7 | 13 | 15.6 | 12.1 | 13.5 | 14.4 | 15.5 | 12 | 70.7 | 90 |
| Sales YoY Gr. | - | -12.3% | -17.1% | 19.6% | -22.3% | 11.8% | 6.3% | 8.1% | -22.7% | 489.3% | - |
| Adj EPS ⓘ | 0.4 | 0.3 | 0.4 | 0.8 | 0.7 | 0.8 | 2.3 | 10.7 | 2.9 | 39.8 | 55.2 |
| YoY Gr. | - | -17.1% | 24.1% | 125% | -17.3% | 22.4% | 179.3% | 365.9% | -73% | 1283.3% | - |
| BVPS (₹) ⓘ | 17 | 17.3 | 17.3 | 17.6 | 24.6 | 27.7 | 30.2 | 31.9 | 32.3 | 265.8 | 307.1 |
| Adj Net Profit ⓘ | 0.2 | 0.2 | 0.2 | 0.5 | 0.4 | 0.6 | 1.7 | 8 | 2.2 | 34.2 | 47 |
| Cash Flow from Ops. ⓘ | 0.2 | 0.9 | 0.2 | -0.8 | 0.5 | 1.1 | 2.8 | 8 | 1.7 | 28.5 | - |
| Debt/CF from Ops. ⓘ | 33.8 | 8.5 | 33.4 | -7.6 | 13.7 | 3.2 | 0.7 | 0.3 | 1.2 | 0 | - |
CAGR Colour Code Guide ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | 16.5% | 42.4% | 70.1% | 489.3% | ||||
| Adj EPS ⓘ | 69.2% | 126.4% | 159.1% | 1283.3% | ||||
| BVPSⓘ | 35.7% | 60.9% | 106.4% | 722.3% | ||||
| Share Price | 67.3% | 89.9% | 60.5% | 122.5% | ||||
Performance Ratio Colour Code Guide ⓘ
| Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity % ⓘ | 2.1 | 1.7 | 2.1 | 3.9 | 2.7 | 3.4 | 7.9 | 34.4 | 9 | 27.1 | 19.3 |
| Op. Profit Mgn % ⓘ | 7 | 6.6 | 8.2 | 7 | 3.6 | -1.8 | -8.4 | -7.9 | -7.8 | 49.6 | 56.5 |
| Net Profit Mgn % ⓘ | 1.2 | 1.2 | 1.8 | 3.3 | 3.6 | 4.5 | 12 | 51.6 | 18 | 48.4 | 52.9 |
| Debt to Equity ⓘ | 0.7 | 0.7 | 0.7 | 0.5 | 0.4 | 0.2 | 0.1 | 0.1 | 0.1 | 0 | - |
| Working Cap Days ⓘ | 390 | 445 | 529 | 488 | 665 | 597 | 549 | 521 | 686 | 214 | 220 |
| Cash Conv. Cycle ⓘ | 168 | 203 | 273 | 288 | 425 | 389 | 357 | 318 | 427 | 121 | 191 |
Sales growth is growing at healthy rate in last 3 years 70.14%
Net Profit is growing at healthy rate in last 3 years 159.12%
Sales growth is good in last 4 quarters at 34.38%
Return on Equity has declined versus last 3 years average to 19.30%
| Standalone | Consolidated | |
|---|---|---|
| TTM EPS (₹) | 55.2 | 56 |
| TTM Sales (₹ Cr.) | 89.5 | 97 |
| BVPS (₹.) ⓘ | 307.1 | 303.1 |
| Reserves (₹ Cr.) ⓘ | 258 | 252 |
| P/BV ⓘ | 5.48 | 5.55 |
| PE ⓘ | 30.48 | 30.05 |
| From the Market | |
|---|---|
| 52 Week Low / High (₹) | 695.00 / 2350.00 |
| All Time Low / High (₹) | 4.81 / 2350.00 |
| Market Cap (₹ Cr.) | 1,444 |
| Equity (₹ Cr.) | 8.6 |
| Face Value (₹) | 10 |
| Industry PE ⓘ | 33.5 |
| Mar'24 | YoY Gr. Rt. % | Jun'24 | YoY Gr. Rt. % | Sep'24 | YoY Gr. Rt. % | Dec'24 | YoY Gr. Rt. % | |
|---|---|---|---|---|---|---|---|---|
| Sales (₹ Cr.)ⓘ | 1,187 | -8.1 | 657 | 35.1 | 590 | 36.8 | 800 | 60.7 |
| Adj EPS (₹) ⓘ | 20.2 | -13.4 | 2 | N/A | 0.5 | N/A | 10.5 | 294.8 |
| Op. Profit Mgn % ⓘ | 19.67 | -176 bps | 11.09 | 2761 bps | 8.72 | 1114 bps | 13.93 | 1078 bps |
| Net Profit Mgn % ⓘ | 15.38 | -94 bps | 2.70 | 1398 bps | 0.68 | 711 bps | 11.89 | 704 bps |
| Pledged * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Company Name | CMP(₹) | |||||||
|---|---|---|---|---|---|---|---|---|
| BASF India | 4,481 | -146.3 (-3.2%) | Small Cap | 13,767 | 141.8 | 4.3 | 32.6 | 5.5 |
| Bayer CropScience | 4,731 | 2.5 (0.1%) | Small Cap | 5,103 | 115.9 | 14.3 | 40.8 | 6.8 |
| Sumitomo Chemical | 485.9 | -6.5 (-1.3%) | Small Cap | 2,833 | 10.3 | 13 | 47.9 | 8.8 |
| Rallis India | 208.6 | -3.7 (-1.7%) | Small Cap | 2,604 | 8.4 | 6.5 | 25.1 | - |
| Sharda Cropchem | 545.5 | 1 (0.2%) | Small Cap | 2,603 | 30.3 | 6.3 | 18 | 2.3 |
| Insecticides India | 592.9 | 4.5 (0.8%) | Small Cap | 1,966 | 46 | 5 | 12.8 | 1.5 |
| Best Agrolife | 287.2 | -5.9 (-2%) | Small Cap | 1,798 | 14 | 1 | 20.9 | 1.7 |
| NACL Industries | 92.3 | 12.7 (15.9%) | Small Cap | 1,781 | -1.9 | -2.7 | - | 3.2 |
| Dhanuka Agritech | 1,117.3 | -38.7 (-3.3%) | Small Cap | 1,759 | 61.5 | 13.5 | 18.8 | 4 |
| Heranba Industries | 214.8 | 3.3 (1.5%) | Small Cap | 1,275 | 18.1 | 5 | 11.7 | 0.9 |
| PARTICULARS | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 18 | 16 | 13 | 16 | 12 | 14 | 14 | 16 | 12 | 71 |
| Operating Expenses ⓘ | 17 | 15 | 12 | 14 | 12 | 14 | 16 | 17 | 13 | 36 |
| Manufacturing Costs | 2 | 2 | 8 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Material Costs | 10 | 8 | 0 | 10 | 9 | 10 | 11 | 12 | 9 | 20 |
| Employee Cost | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 3 |
| Other Costs ⓘ | 3 | 3 | 3 | 2 | 2 | 2 | 3 | 3 | 2 | 11 |
| Operating Profit ⓘ | 1 | 1 | 1 | 1 | 0 | 0 | -1 | -1 | -1 | 35 |
| Operating Profit Margin (%) | 7.0% | 6.6% | 8.2% | 7.0% | 3.6% | -1.8% | -8.4% | -7.9% | -7.8% | 49.6% |
| Other Income ⓘ | 0 | 0 | 0 | 0 | 1 | 1 | 4 | 10 | 4 | 12 |
| Interest ⓘ | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Exceptional Items ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax ⓘ | 0 | 0 | 0 | 1 | 0 | 1 | 2 | 8 | 3 | 46 |
| Tax ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12 |
| Profit After Tax | 0 | 0 | 0 | 1 | 0 | 1 | 2 | 8 | 2 | 34 |
| PAT Margin (%) | 1.2% | 1.2% | 1.8% | 3.3% | 3.6% | 4.5% | 12.0% | 51.6% | 18.0% | 48.4% |
| Adjusted EPS (₹) | 0.4 | 0.3 | 0.4 | 0.8 | 0.7 | 0.8 | 2.3 | 10.7 | 2.9 | 39.9 |
| Dividend Payout Ratio (%) | 0% | 0% | 83% | 61% | 74% | 85% | 44% | 98% | 87% | 8% |
| PARTICULARS | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 |
|---|---|---|---|---|---|---|---|---|---|---|
Equity and Liabilities | ||||||||||
| Shareholders Fund | 11 | 11 | 11 | 11 | 16 | 21 | 23 | 24 | 24 | 228 |
| Share Capital ⓘ | 6 | 6 | 6 | 6 | 6 | 7 | 7 | 7 | 7 | 9 |
| Reserves ⓘ | 4 | 5 | 5 | 5 | 9 | 13 | 15 | 16 | 17 | 219 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debt | 7 | 7 | 8 | 6 | 6 | 4 | 2 | 3 | 2 | 1 |
| Long Term Debt | 2 | 2 | 3 | 2 | 2 | 1 | 1 | 1 | 1 | 1 |
| Short Term Debt | 5 | 5 | 5 | 3 | 4 | 2 | 1 | 2 | 1 | 0 |
| Trade Payables | 6 | 4 | 4 | 3 | 4 | 3 | 3 | 4 | 2 | 4 |
| Others Liabilities ⓘ | 1 | 1 | 1 | 6 | 1 | 1 | 1 | 2 | 1 | 18 |
| Total Liabilities ⓘ | 25 | 24 | 24 | 26 | 27 | 28 | 29 | 32 | 30 | 250 |
Fixed Assets | ||||||||||
| Gross Block | 5 | 5 | 6 | 6 | 6 | 6 | 6 | 8 | 8 | 13 |
| Accumulated Depreciation | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 5 | 6 |
| Net Fixed Assetsⓘ | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 3 | 3 | 7 |
| CWIP ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investmentsⓘ | 0 | 0 | 1 | 1 | 1 | 4 | 4 | 4 | 4 | 128 |
| Inventories | 4 | 3 | 3 | 3 | 4 | 3 | 3 | 3 | 3 | 8 |
| Trade Receivables | 13 | 13 | 13 | 14 | 14 | 14 | 14 | 14 | 14 | 36 |
| Cash Equivalents | 0 | 0 | 0 | 1 | 1 | 1 | 2 | 2 | 1 | 55 |
| Others Assetsⓘ | 5 | 5 | 4 | 4 | 4 | 4 | 5 | 6 | 6 | 16 |
| Total Assets ⓘ | 25 | 24 | 24 | 26 | 27 | 28 | 29 | 32 | 30 | 250 |
| PARTICULARS | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow From Operating Activity ⓘ | 0 | 1 | 0 | -1 | 0 | 1 | 3 | 8 | 2 | 28 |
| PBT ⓘ | 0 | 0 | 0 | 1 | 0 | 1 | 2 | 8 | 3 | 46 |
| Adjustment ⓘ | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | -5 |
| Changes in Working Capital ⓘ | -1 | -0 | -1 | -2 | -1 | -0 | 1 | -1 | -1 | -2 |
| Tax Paid ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 | -11 |
| Cash Flow From Investing Activity ⓘ | 0 | 0 | 0 | 0 | 0 | -2 | 0 | -2 | 0 | -20 |
| Capex | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2 | 0 | -1 |
| Net Investments | 0 | 0 | 0 | -1 | 0 | -2 | 0 | 0 | 0 | -20 |
| Others ⓘ | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash Flow From Financing Activityⓘ | 0 | -1 | 0 | 1 | 0 | 1 | -2 | -6 | -3 | -4 |
| Net Proceeds from Shares ⓘ | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
| Net Proceeds from Borrowing ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Paid ⓘ | -1 | -1 | -1 | -1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividend Paid ⓘ | 0 | 0 | 0 | 0 | 0 | -1 | 0 | -7 | -2 | -2 |
| Others ⓘ | 1 | 0 | 1 | 2 | 0 | 1 | -1 | 1 | -1 | -1 |
| Net Cash Flow ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | -1 | 5 |
| PARTICULARS | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ratios | ||||||||||
| ROE (%) | 2.07 | 1.71 | 2.08 | 4.67 | 3.19 | 3.36 | 7.91 | 34.38 | 8.97 | 27.15 |
| ROCE (%) | 6.09 | 4.78 | 5.49 | 6.07 | 4.17 | 4.1 | 9.45 | 33.53 | 10.81 | 36.55 |
| Asset Turnover Ratio | 0.8 | 0.71 | 0.59 | 0.63 | 0.46 | 0.49 | 0.5 | 0.51 | 0.39 | 0.51 |
| PAT to CFO Conversion(x) | N/A | N/A | N/A | -1 | N/A | 1 | 1.5 | 1 | 1 | 0.82 |
| Working Capital Days | ||||||||||
| Receivable Days | 240 | 279 | 337 | 317 | 427 | 382 | 359 | 334 | 427 | 129 |
| Inventory Days | 67 | 67 | 78 | 74 | 110 | 100 | 75 | 63 | 87 | 28 |
| Payable Days | 213 | 216 | 0 | 129 | 148 | 121 | 97 | 99 | 118 | 52 |
Kilpest India is one of India's leading agri-based companies. Kilpest is an ISO certified company and has representation in India in the field of agriculture business comprising crop protection products and public health products, bio products, micro-nutrients and mix fertilizers. The company has one of the most advance Research & Development facility at its Bhopal plant and also has Biological Research Centre. The products are manufactured to high international! BlS specifications with stringent quality control from raw material procurement to finished goods despatch.
The products are manufactured to high international / BIS specifications with stringent quality control from raw material procurement to finished goods despatch. The company's manufacturing process is complimented with the technical expertise and it has attained high standard suited to customer needs.
The company has a nationwide distribution network. Kilpest is also doing toll formulations for multinational industries. Products of Kilpest are exported to several countries. The company is listed on the Bombay Stock Exchange. It is also registered with D&B, D-V-N-S.
Products range of the company includes:
Clientele:
Achievements/ recognition:
An ISO certified company
MoneyWorks4Me rating and ranking of funds for SIP is available to subscribers only. Moneyworks4Me is not a rating and ranking agency, however it is required that users have a way of selecting funds and building a Portfolio. The method used by it are described below to enable users to understand the logic behind the rating and ranking Subscriber will find more details on this in the various content made available from time to time. In case you need more please write to besafe@moneyworks4Me.com
MoneyWorks4Me rates and ranks mutual funds based on the following data-driven system:
Funds ranking in screeners: Performance Consistency and Quality are two parameters used for ranking funds for SIP. The ranking as follows GG, GO, GR, OG, OO, OR, RG, RO and RR.
With the same color-coded funds, the one with the higher Average 3-year rolling returns (over 5 to 10 years), the number that appears in the Performance tag, ranks higher.
Here is the summary:
The third tag Upside Potential is not relevant for SIP. It is relevant for lumpsum investments in Mutual Funds.
Make an informed decision for Stocks
Invest using an intelligent system with powerful data-driven tools that help you identify opportunities and make informed buy-hold-sell decisions
Buy quality Stocks when they are available at reasonable prices and supported by an upward price trend and Sell when they are Overvalued using the Decizen Rating System. Covers 3500+ stocks
100% Secure Process
Account Discovery
- OTP from CAMS
Account Linking for Stocks & MF
- One OTP per link Eg. NSDL, CDSL, CAMS, KFin etc.
One Click Upload for your Current Portfolio and Future Transactions!
Don't miss out! First 10 users today get it FREE
With this 4 hrs Masterclass, you’ll be able to:
Download APP
